Search
for
Sort by
Research 31–60 of 1000+
- IMPACT OF LOW DOSE FINASTERIDE FOR THE TREATMENT OF ANDROGENIC ALOPECIA ON SERUM PROSTATE SPECIFIC ANTIGEN (PSA) LEVELS IN MEN PARTICIPATED IN POPULATION-BASED SCREENING FOR PROSTATE CANCER
- Serum prostate spesific antigen levels in women with androgenetic alopecia
- Change in Prostate Specific Antigen Concentration in Men with Prostate Specific Antigen Less than 2.5 ng/ml Taking Low Dose Finasteride or Dutasteride for Male Androgenetic Alopecia
- Cutaneous melanoma, prostate-specific antigen testing and the subsequent risk of prostate cancer diagnosis: a prospective analysis of the 45 and Up Study
- Liarozole—a novel treatment approach for advanced prostate cancer: results of a large randomized trial versus cyproterone acetate
- Finasteride-its impact on sexual function and prostate cancer
- Androgenetic alopecia and polymorphism of the androgen receptor gene (SNP rs6152) in patients with benign prostate hyperplasia or prostate cancer
- Alcohol and Prostate Cancer: Time to Draw Conclusions
- Abiraterone and spironolactone in prostate cancer: a combination to avoid
- Prostate cancer update: 2007
- Hormonal treatment for male-pattern hair loss: implications for cancer of the prostate?
- Antiandrogenic activity of Riboflavin 5′-phosphate (FMN) in 22Rv1 and LNCaP human prostate cancer cell lines
- Prostate Carcinoma, what would be the best to do ?
- Testosterone Deficiency is Not Protective Against the Development of Adenocarcinoma of the Prostate in a Type 1 Diabetic Patient
- Total prostate volume as risk factor for semen pathologies in ageing male
- S5 IS THE RADICAL PROSTATECTOMY THE BEST CHOICE FOR PATIENTS WITH LOCALLY ADVANCED PROSTATE CANCER?
- IMPLICAÇÕES DA TOMA CRÓNICA DA FINASTERIDE PARA A ALOPÉCIA ANDROGENÉTICA NO CARCINOMA DA PRÓSTATA
- Patients with a large prostate show a higher prevalence of androgenetic alopecia
- Are PSA adjustments necessary for prostate cancer screening in men taking finasteride for hair loss?
- The Effects of Transdermal Dihydrotestosterone in the Aging Male: A Prospective, Randomized, Double Blind Study
- Cinnamomi Cortex (Cinnamomum verum) Suppresses Testosterone-induced Benign Prostatic Hyperplasia by Regulating 5α-reductase
- Effect of finasteride and/or terazosin on serum PSA: Results of VA cooperative study #359
- Dutasteride for the treatment of benign prostatic hyperplasia
- Ganoderma lucidum is an inhibitor of testosterone-induced prostatic hyperplasia in rats
- Finasteride: The First 5α-Reductase Inhibitor
- Corn silk extract improves benign prostatic hyperplasia in experimental rat model
- Efficacy and safety of 5 alpha-reductase inhibitor monotherapy in patients with benign prostatic hyperplasia: A meta-analysis
- Benign prostatic hyperplasia and male lower urinary symptoms: A guide for family physicians
- Effects of <i>Lespedeza Cuneata aqueous extract</i> on testosterone-induced prostatic hyperplasia
- Dutasteride, a novel dual 5-A reductase inhibitor, reduces serum DHT to a greater extent versus finasteride and achieves finasteride maximal reduction in a larger proportion of patients